Pharma’s response to the COVID-19 pandemic and its impact on public image
Pharmaceutical companies have historically struggled with negative public perception. In January 2020, before the COVID-19 pandemic, only...
Search
Collin Kruczek
- Mar 1, 2021
- 2 min
Merck Targets Autoimmune Treatment in Pandion Therapeutics
On Thursday, February 26th Merck announced that it will pay out roughly $1.85 billion to acquire Pandion Therapeutics, a biotech hoping...
29 views0 comments
Mackeyan Martin
- Feb 15, 2021
- 2 min
Wall Street Bets vs. Melvin Capital
In recent weeks, the stock market has seen an unprecedented battle between two powerhouse groups. The first being a hedge fund by the...
26 views0 comments
Chris Biser
- Feb 1, 2021
- 3 min
The Case for Supernus Pharmaceuticals
Supernus Pharmaceuticals is a small(ish)-cap specialty pharmaceuticals company that is largely involved in neuroscience and psychiatry....
25 views0 comments
Brooke Kulusich
- Jan 26, 2021
- 1 min
Annual Biotech Investment Fantasy League Results
The Pittsburgh Pharmacy Investment Portfolio (PPIP) wrapped up its Biotech Investment Fantasy League (BIFL) competition at its annual...
22 views0 comments
Collin Kruczek
- Nov 30, 2020
- 3 min
Reinventing the vaccine
On November 16th, 2020 Moderna, who has never had a drug or vaccine go to market, has announced efficacy data on the COVID-19 vaccine...
21 views0 comments
Chris Biser
- Nov 18, 2020
- 3 min
Aducanumab takes Biogen stock for a wild ride
Aducanumab is a monoclonal antibody that selectively targets and decreases levels of the amyloid beta plaques that are a hallmark of...
54 views0 comments
jlm360
- Nov 2, 2020
- 3 min
Gilead stock price fluctuates as remdesivir earns FDA approval
On October 22nd, 2020, The FDA approved Gilead Science’s antiviral medication, remdesivir, as a COVID-19 treatment for patients requiring...
75 views0 comments
amd240
- Oct 15, 2020
- 2 min
The pros of investing in an orphan drug company
What is an orphan drug? Rare diseases are defined by the Food and Drug Administration and are based on the size of the patient population...
28 views0 comments
Shane Seager
- Sep 2, 2020
- 2 min
Merck’s August performance drives PPIP’s growth
Merck makes up approximately 6.5% of Pittsburgh Pharmacy Investment Portfolio’s holdings. PPIP bought 76 shares of Merck at a price of...
29 views0 comments
Ethan Markowski
- Aug 1, 2020
- 2 min
PPIP Rides Success of AstraZeneca
As members of the Pittsburgh Pharmacy Investment Portfolio (PPIP), student pharmacists utilize the clinical knowledge that we learn in...
35 views0 comments
Annalisa Nguyen
- Apr 21, 2019
- 1 min
Due Diligence Presentations
This past week, 21 of our PPIP analysts made recommendations to change or keep our current portfolio holdings. Details regarding changes...
14 views0 comments
Annalisa Nguyen
- Apr 6, 2019
- 2 min
Industry News Update: 4/6
This week in pharma: Arbor took a novel marketing approach by recruiting former NBA basketball star Shaquille O’Neal as the face of the...
9 views0 comments
Josh Cinicola
- Mar 28, 2019
- 3 min
Industry News Update: 3/29
This week in pharma, AbbVie is showing signs of a strong year. Skyrizi, their, recent collaboration with Boehringer Ingelheim, just got...
11 views0 comments
Annalisa Nguyen
- Mar 22, 2019
- 2 min
Industry News Update: 3/22
This week in pharma: On Tuesday, March 19, the FDA approved the first postpartum depression drug brexanolone (Zulresso—Sage...
7 views0 comments
Josh Cinicola
- Mar 15, 2019
- 3 min
Industry News Update: 3/15
Big news this week in pharma! the Trump administration appointed Dr. Ned Sharpless as the interim director of the FDA after Former...
59 views0 comments
Annalisa Nguyen
- Mar 7, 2019
- 2 min
Industry News Update: 3/7
This week in pharma: Johnson & Johnson’s esketamine, or Spravato, won the agency approval on Tuesday, March 5, 2019. Spravato is a nasal...
16 views0 comments
Josh Cinicola
- Mar 4, 2019
- 1 min
Industry News Update: 3/1
This week in Pharma, Akron Pharmaceuticals, which recently received 2 FDA manufacturing warnings, got hit with a form 483 for stability...
15 views0 comments
Annalisa Nguyen
- Feb 14, 2019
- 1 min
Industry News Update: 2/14
This week in pharma: Merck announced their data from three pivotal phase 3 trials focusing on treating advanced prostate cancer. The...
20 views0 comments
Josh Cinicola
- Feb 7, 2019
- 1 min
Industry News Update
This week in pharma, the FDA approved the first generic biosimilar of GSK's big seller Advair. Although GSK has been working with Part D...
15 views0 comments